中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

59 records (took 0.021 seconds)

    Photoacid generator and photoresist comprising same
    21.
    发明授权
    Photoacid generator and photoresist comprising same 有权
    光生酸产生剂和包含其的光致抗蚀剂

    公开(公告)号：US09146470B2

    公开(公告)日：2015-09-29

    申请号：US14532134

    申请日：2014-11-04

    Applicant: Rohm and Haas Electronic Materials LLC

    Inventor： Emad Aqad ,  Cheng-Bai Xu ,  Mingqi Li ,  Shintaro Yamada ,  William Williams, III

    IPC: G03F7/30 ,  G03F7/004 ,  G03F7/039 ,  G03F7/20 ,  G03F7/038 ,  C07D313/08 ,  C07D327/04 ,  C07C309/65 ,  C07C311/09 ,  C07D493/18 ,  C07D497/18 ,  C07D313/10

    CPC classification number: G03F7/30 ,  C07C309/65 ,  C07C311/09 ,  C07C2603/74 ,  C07D313/08 ,  C07D313/10 ,  C07D327/04 ,  C07D493/18 ,  C07D497/18 ,  G03F7/0045 ,  G03F7/0046 ,  G03F7/038 ,  G03F7/0397 ,  G03F7/2041

    Abstract: A photoacid generator compound has the formula (I): [A-(CHR1)p]k-(L)-(CH2)m—(C(R2)2)nSO3−Z+  (I) wherein A is a substituted or unsubstituted, monocyclic, polycyclic, or fused polycyclic C5 or greater cycloaliphatic group optionally comprising O, S, N, F, or a combination comprising at least one of the foregoing, R1 is H, a single bond, or a substituted or unsubstituted C1-30 alkyl group, wherein when R1 is a single bond, R1 is covalently bonded to a carbon atom of A, each R2 is independently H, F, or C1-4 fluoroalkyl, wherein at least one R2 is not hydrogen, L is a linking group comprising a sulfonate group, a sulfonamide group, or a C1-30 sulfonate or sulfonamide-containing group, Z is an organic or inorganic cation, p is an integer of 0 to 10, k is 1 or 2, m is an integer of 0 or greater, and n is an integer of 1 or greater. A precursor compound to the photoacid generator, a photoresist composition including the photoacid generator, and a substrate coated with the photoresist composition, are also disclosed.

    Abstract translation: 光生酸化合物具有式（I）：其中A是取代或未取代的（A）（A）所示的[A-（CHR1）p] k-（L） - （CH2）m-（C（R2）2）nSO3-Z + ，任选包含O，S，N，F或包含至少一个前述的组合的单环，多环或稠合多环C 5或更多脂环族基团，其中R 1为H，单键或取代或未取代的C1-30 烷基，其中当R 1为单键时，R 1与A的碳原子共价键合，每个R 2独立地为H，F或C 1-4氟代烷基，其中至少一个R 2不是氢，L是连接基团 包括磺酸酯基，磺酰胺基或含C 1〜30磺酸酯或磺酰胺的基团，Z为有机或无机阳离子，p为0〜10的整数，k为1或2，m为0的整数 以上，n为1以上的整数。 还公开了光致酸产生剂的前体化合物，包含光致酸产生剂的光致抗蚀剂组合物和涂有光致抗蚀剂组合物的基材。

    Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof
    22.
    发明授权
    Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof 有权
    盐酸奥洛他定的多形态形式及其制备奥洛他定及其盐的方法

    公开(公告)号：US07687646B2

    公开(公告)日：2010-03-30

    申请号：US11392098

    申请日：2006-03-28

    Applicant: Thomas Bader ,  Hans-Ulrich Bichsel ,  Bruno Gilomen ,  Imelda Meyer-Wilmes ,  Mark Sundermeier

    Inventor： Thomas Bader ,  Hans-Ulrich Bichsel ,  Bruno Gilomen ,  Imelda Meyer-Wilmes ,  Mark Sundermeier

    IPC: C07D313/10

    CPC classification number: C07F9/5325 ,  C07D313/12 ,  C07F9/5352 ,  C07F9/5442

    Abstract: The present invention provides a novel polymorphic form of olopatadine hydrochloride ([(Z)-3-(dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid hydrochloride), a selective histamine H1-receptor antagonist that is used for the treatment of ocular symptoms of seasonal allergic conjunctivitis. The present invention also provides novel methods for producing olopatadine on a large scale, and in a manner that is cost effective, provides a low level of impurities and eliminates the need to use the costly and dangerous base, butyllithium, which is used in prior art reactions for making olopatadine. The present invention further provides novel processes for carrying out a large scale production of 3-dimethylaminopropyltriphenylphosphonium bromide and its corresponding hydrobromide salt, which are employed in the production of olopatadine, and pharmaceutically acceptable salts of olopatadine.

    Abstract translation: 本发明提供盐酸奥洛他定（[（Z）-3-（二甲基氨基）亚丙基] -6,11-二氢二苯并[b，e]氧杂七环素-2-乙酸盐酸盐），选择性组胺H1受体 拮抗剂，用于治疗季节性过敏性结膜炎的眼部症状。 本发明还提供了大规模生产奥洛他定的新方法，并且以成本有效的方式提供低水平的杂质，并且不需要使用现有技术中使用的昂贵且危险的碱，丁基锂 奥洛他定的反应。 本发明进一步提供了用于生产奥洛他定的3-二甲基氨基丙基三苯基溴化鏻及其相应的氢溴酸盐的大规模生产的新方法和奥洛他定的药学上可接受的盐。

    Amino-substituted tetracyclic compounds
    26.
    发明授权
    Amino-substituted tetracyclic compounds 失效
    氨基取代的四环化合物

    公开(公告)号：US4125718A

    公开(公告)日：1978-11-14

    申请号：US851770

    申请日：1977-11-15

    Applicant: Willem J. van der Burg

    Inventor： Willem J. van der Burg

    IPC: C07D223/22 ,  C07D401/06 ,  C07D413/06 ,  C07D313/10

    CPC classification number: C07D401/06 ,  C07D223/22 ,  C07D413/06

    Abstract: The invention discloses novel compounds of the general formula: ##STR1## and salts thereof, in which X stands for oxygen, sulphur, the group >NR.sub.7 or the group --CR.sub.8 R.sub.9 --;R.sub.1, r.sub.2, r.sub.3 and R.sub.4 represent hydrogen, hydroxy, halogen, alkyl (1-6 C), alkoxy (1-6 C), alkylthio (1-6 C) or trifluoromethyl;R.sub.5 and R.sub.6 represent hydrogen, alkyl (1-6 C), aralkyl (7-10 C) or together in combination with the nitrogen atom a heterocyclic five- or six-membered ring;R.sub.7 stands for hydrogen or alkyl (1-4 C);R.sub.8 and R.sub.9 stand for hydrogen or methyl,n is the number 0, 1 or 2 andThe dotted line means an optional C--C bond,With valuable central nervous system (CNS) activities, especially antidepressant activity.

    Abstract translation: 本发明公开了通式为：其中X代表氧，硫，基团> NR7或基团-CR8R9-的新颖化合物及其盐。 R1，R2，R3和R4代表氢，羟基，卤素，烷基（1-6C），烷氧基（1-6C），烷硫基（1-6C）或三氟甲基; R5和R6代表氢，烷基（1-6C），芳烷基（7-10C）或与氮原子一起与杂环五元或六元环结合; R7代表氢或烷基（1-4C）; R8和R9代表氢或甲基，N为0,1或2号，带电线表示可选的C-C键，具有有价值的中央神经系统（CNS）活性，特别是抗抑郁活性。

    Benzoxepin derivatives
    27.
    发明授权
    Benzoxepin derivatives 失效
    苯并西林衍生物

    公开(公告)号：US3899512A

    公开(公告)日：1975-08-12

    申请号：US46260474

    申请日：1974-04-22

    Applicant: COLGATE PALMOLIVE CO

    Inventor： FREEDMAN JULES

    IPC: C07D313/08 ,  C07D313/10

    CPC classification number: C07D313/10 ,  C07D313/08

    Abstract: The compounds are benzoxepinones which are central nervous system depressants. A compound disclosed is 8,9,10,11-tetrahydro3-hydroxydibenz(b,d)oxepin-6(7H)one.

    Abstract translation: 这些化合物是作为中枢神经系统抑制剂的苯并酮。 所公开的化合物是8,9,10,11-四氢-3-羟基二苯并[b，d]氧杂七环素-6（7H）酮。

Patent Agency Ranking